StockData
Mesoblast Ltd logo

Mesoblast Ltd (MESO) stock

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.64−0.27 (-2.27%)

Close on Nov 18, 2026Market cap $1.51BP/E –Yield –

Mesoblast price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Mesoblast's price to sales ratio was 14.7× on Nov 11, 2026, against 121.0× a year earlier. Over the last 5 years it ranged from 14.7× to 336.7×, with a median of 69.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202614.7×−112.0
2025Dec 31, 2025126.7×−204.3
2024Dec 31, 2024331.0×+308.2
2023Dec 29, 202322.8×−27.0
2022Dec 30, 202249.8×−11.6
2021Dec 31, 202161.4×+4.5
2020Dec 31, 202056.9×+23.7
2019Dec 31, 201933.1×+19.1
2018Dec 31, 201814.1×−179.2
2017Dec 29, 2017193.2×+184.1
2016Dec 30, 20169.2×–

More Mesoblast figures

See a number that looks wrong?